4.4 Article

BMP9 ameliorates amyloid pathology by promoting low-density lipoprotein receptor-related protein 1 expression in APP/PS1 transgenic mice

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles

Powsali Ghosh et al.

Summary: Alzheimer's disease is a common neurodegenerative disorder of the older generation, with neuroinflammation playing a significant role in its pathogenesis. Genome-wide association studies have identified the relationship between single nucleotide polymorphisms in genes related to neuroinflammation and the risk of developing Alzheimer's disease.

NEUROCHEMISTRY INTERNATIONAL (2021)

Review Biochemistry & Molecular Biology

Neuroinflammation in Alzheimer's Disease

Isaac G. Onyango et al.

Summary: Alzheimer's disease is a neurodegenerative disease associated with aging, with no effective treatments currently available. Inflammaging may contribute to the progression of neurodegeneration in AD.

BIOMEDICINES (2021)

Review Neurosciences

Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer's Disease

Sadayuki Hashioka et al.

Summary: The exact contributions of reactive glia to AD pathogenesis remain difficult to define, and both beneficially and adversely activated cell populations of microglia could be identified at various stages of AD. A candidate drug for AD, nimodipine, potentially targets both astrocytes and microglia and has shown consistent beneficial effects in basic experimental and clinical studies. Peripheral inflammation, from diseases such as obesity, type 2 diabetes mellitus, and periodontitis, can exacerbate neuroinflammation and increase the risk or progression of AD, suggesting that reducing peripheral inflammation could be an effective strategy for lowering AD prevalence.

CURRENT NEUROPHARMACOLOGY (2021)

Review Clinical Neurology

Neuroinflammation in Alzheimer's Disease: Microglia, Molecular Participants and Therapeutic Choices

Haijun Wang et al.

CURRENT ALZHEIMER RESEARCH (2019)

Review Chemistry, Multidisciplinary

Endothelial LRP1-A Potential Target for the Treatment of Alzheimer's Disease

Steffen E. Storck et al.

PHARMACEUTICAL RESEARCH (2017)

Article Medicine, Research & Experimental

Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier

Steffen E. Storck et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Review Clinical Neurology

Neuroinflammation in Alzheimer's disease: Current evidence and future directions

Valeria Calsolaro et al.

ALZHEIMERS & DEMENTIA (2016)

Review Endocrinology & Metabolism

Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease

Sagar H. Barage et al.

NEUROPEPTIDES (2015)

Review Neurosciences

BMP signaling in axon regeneration

Jian Zhong et al.

CURRENT OPINION IN NEUROBIOLOGY (2014)

Article Pharmacology & Pharmacy

BMP signaling in development and diseases: A pharmacological perspective

Amitabha Bandyopadhyay et al.

BIOCHEMICAL PHARMACOLOGY (2013)

Article Neurosciences

LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-β

Takahisa Kanekiyo et al.

JOURNAL OF NEUROSCIENCE (2012)

Review Biotechnology & Applied Microbiology

Alzheimer's disease: strategies for disease modification

Martin Citron

NATURE REVIEWS DRUG DISCOVERY (2010)

Review Medicine, General & Internal

Alzheimer's disease

Kaj Blennow et al.

LANCET (2006)

Article Multidisciplinary Sciences

Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons

I Lopez-Coviella et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)